LM Chen
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Cancer, Hypoxia, and Metabolism 1
- Protease and Inhibitor Mechanisms 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- John K. Chan (1 shared paper)Kathryn Osann (1 shared paper)Daniel Stuart Kapp (1 shared paper)C. Bethan Powell (1 shared paper)Jacob Y. Shin (1 shared paper)Jia Zhao (1 shared paper)Yang Chih-Yu (1 shared paper)X-J Li (1 shared paper)
- Journals
- The Lancet (1 paper)American Journal of Kidney Diseases (1 paper)British Journal of Cancer (1 paper)Annals of Oncology (1 paper)Oncogenesis (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
LM Chen
14 papers receiving 1.7k citations
LM Chen's Hit Papers
Peers
Comparison fields: 5 of 69
- Oncology 878
- Reproductive Medicine 336
- Obstetrics and Gynecology 211
- Cancer Research 106
- Genetics 217
Countries citing papers authored by LM Chen
This map shows the geographic impact of LM Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LM Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LM Chen more than expected).
Fields of papers citing papers by LM Chen
This network shows the impact of papers produced by LM Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LM Chen. The network helps show where LM Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside LM Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 1405 |
| 2 | 2008 | 192 | |
| 3 | 2010 | 63 | |
| 4 | 1998 | 32 | |
| 5 | 2017 | 27 | |
| 6 | 2020 | 25 | |
| 7 | 2015 | 13 | |
| 8 | 2010 | 9 | |
| 9 | 2012 | 4 | |
| 10 | 2023 | 3 | |
| 11 | Study on the accelerator physics issues in the storage ring of BEPC II | 2006 | 2 |
| 12 | 2017 | 2 | |
| 13 | INVERSE HALFTONING FOR MONOCHROME PICTURES | 1994 | 1 |
| 14 | 2011 | 1 | |
| 15 | 2023 | 1 | |
| 16 | Studies of interactions of femtosecond laser pulses with foil targets | 2001 | 0 |
| 17 | 2025 | 0 |
About LM Chen
LM Chen is a scholar working on Cancer Research, Hepatology, Physiology, Clinical Biochemistry and Obstetrics and Gynecology, having authored 17 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Antifungal resistance and susceptibility (1 paper), Protease and Inhibitor Mechanisms (1 paper), Cervical Cancer and HPV Research (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Laser-Plasma Interactions and Diagnostics (1 paper) and Dialysis and Renal Disease Management (1 paper). The work is most often cited by research in Oncology (878 citations), Reproductive Medicine (336 citations), Obstetrics and Gynecology (211 citations), Cancer Research (106 citations) and Genetics (217 citations). LM Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include John K. Chan, Kathryn Osann, Daniel Stuart Kapp, C. Bethan Powell, Jacob Y. Shin, Jia Zhao, Yang Chih-Yu, X-J Li, Jayu Jen and Ya Chen. Their work appears in journals such as The Lancet, American Journal of Kidney Diseases, British Journal of Cancer, Annals of Oncology and Oncogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.